ReviewJournal of Zhejiang University. Science. B

Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma.

He Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.